3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
22
Fatigue
16
Neoplasms
8
Depression
6
Pain
5
Colorectal Neoplasms
4
Vomiting
3
Ovarian Neoplasms
3
Nausea
3
Lung Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Anxiety Disorders
3
Sleep Wake Disorders
2
Sleep Initiation and Maintenance Disorders
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Polycystic Ovary Syndrome
2
Parasomnias
2
Oligodendroglioma
2
Obesity
2
Motor Activity
2
Meningioma
2
Medulloblastoma
2
Lymphedema
2
Leukemia
2
Head and Neck Neoplasms
2
Gliosarcoma
2
Glioblastoma
2
Interventions
Morphine
6
Surveys and Questionnaires
5
Ketamine
4
Sodium Chloride
3
Saline Solution
3
Lidocaine
3
Educational Status
3
Dexmedetomidine
3
Cognitive Behavioral Therapy
3
Anesthetics, Local
3
Pregabalin
2
Mindfulness-Based Stress Reduction
2
Hypnosis
2
Fentanyl
2
Bupivacaine
2
Botulinum Toxins, Type A
2
Acetaminophen
2
ziconotide
1
tianeptine
1
siltuximab
1
onabotulinum toxin A
1
erenumab
1
Yoga
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
Tramadol
1
Therapeutics
1
Telemedicine
1
Tea
1
Tamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Chronic Pain
×
Yoga
×
Clear all
NCT05121558
2026-02-06
YCT
Dana-Farber Cancer Institute
Phase NA
Active not recruiting
227 enrolled